MarketCap
Facebook
X
TelegramGeschäftsbericht 2025
hinzugefügt 03.01.2026
Aurora Cannabis EBITDA per Share 2011-2026 | ACB
EBITDA per Share Jährlich Aurora Cannabis
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | -1.67 | -5.07 | -3.76 | -1.78 | -0.384 | -0.372 | -1.44 | -0.222 | -0.0252 | -0.0208 | -0.0117 |
Alle Zahlen in CAD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| -0.0117 | -5.07 | -1.34 |
EBITDA per Share anderer Aktien in der Arzneimittelhersteller
| Name | EBITDA per Share | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
Alimera Sciences
ALIM
|
0.27 | - | - | $ 142 M |  USA |
 |
Adamis Pharmaceuticals Corporation
ADMP
|
-0.16 | - | 0.86 % | $ 117 M | USA |
 |
Aerie Pharmaceuticals
AERI
|
-0.86 | - | - | $ 754 M | USA |
 |
Cronos Group
CRON
|
-0.504 | $ 2.66 | -0.56 % | $ 1.4 B |  Canada |
 |
Canopy Growth Corporation
CGC
|
-0.89 | $ 1.28 | 7.8 % | $ 138 M | Canada |
 |
AcelRx Pharmaceuticals
ACRX
|
-1.16 | - | 7.5 % | $ 6.35 M | USA |
 |
Agile Therapeutics
AGRX
|
-9.17 | - | 10.11 % | $ 58.2 M | USA |
 |
Catalent
CTLT
|
-1.44 | - | - | $ 11.5 B | USA |
 |
DURECT Corporation
DRRX
|
-1.4 | - | - | $ 50.1 M | USA |
 |
Calliditas Therapeutics AB (publ)
CALT
|
-10.3 | - | -0.1 % | $ 2.03 B |  Schweden |
 |
HEXO Corp.
HEXO
|
-0.67 | - | 2.45 % | $ 38.1 M | Canada |
 |
Eagle Pharmaceuticals
EGRX
|
6.31 | - | -39.89 % | $ 27.7 M | USA |
 |
Endo International plc
ENDP
|
1.3 | - | - | $ 28.9 M |  Irlanda |
 |
Emergent BioSolutions
EBS
|
-11.7 | $ 13.4 | -3.67 % | $ 686 M | USA |
 |
Evoke Pharma
EVOK
|
-2.22 | - | - | $ 36.6 M | USA |
 |
Athenex
ATNX
|
-10 | - | -23.39 % | $ 1.76 M | USA |
 |
Avadel Pharmaceuticals plc
AVDL
|
-0.42 | $ 21.48 | -0.09 % | $ 2.04 B |  France |
 |
Sundial Growers
SNDL
|
-71 | $ 1.65 | -0.3 % | $ 3.37 M | Canada |
 |
Evolus
EOLS
|
-0.47 | $ 5.72 | 0.97 % | $ 355 M | USA |
 |
Harrow Health
HROW
|
0.05 | $ 50.59 | -0.81 % | $ 1.65 B | USA |
 |
China Pharma Holdings
CPHI
|
-0.11 | $ 1.39 | 2.21 % | $ 24.3 M |  China |
 |
Jupiter Wellness
JUPW
|
0.01 | - | - | $ 33.6 M | USA |
 |
OrganiGram Holdings
OGI
|
-0.36 | $ 1.74 | 3.57 % | $ 402 M | Canada |
 |
Bausch Health Companies
BHC
|
6.1 | $ 7.81 | -1.2 % | $ 2.85 B | Canada |
 |
Lannett Company
LCI
|
-3.52 | - | 1.15 % | $ 7.11 M | USA |
 |
Cumberland Pharmaceuticals
CPIX
|
0.22 | $ 4.78 | -7.96 % | $ 67.2 M | USA |
 |
Neoleukin Therapeutics
NLTX
|
-106 | - | - | $ 193 M | Canada |
 |
Organogenesis Holdings
ORGO
|
0.09 | $ 4.25 | -1.28 % | $ 560 M | USA |
 |
Pacira BioSciences
PCRX
|
0.12 | $ 26.09 | 0.35 % | $ 1.21 B | USA |
 |
PetIQ
PETQ
|
2.8 | - | 1.64 % | $ 400 M | USA |
 |
Perrigo Company plc
PRGO
|
3.19 | $ 14.84 | 1.64 % | $ 2.04 B | USA |
 |
ProPhase Labs
PRPH
|
1.79 | - | - | $ 5.07 M | USA |
 |
Recro Pharma
REPH
|
0.05 | - | -4.76 % | $ 65.3 M | USA |
 |
Radius Health
RDUS
|
-1.13 | - | - | $ 1.42 B | USA |
 |
Rockwell Medical
RMTI
|
-0.22 | $ 1.0 | 4.65 % | $ 23.3 M | USA |
 |
Relmada Therapeutics
RLMD
|
-3.45 | $ 4.4 | 1.85 % | $ 132 M | USA |
 |
Sonoma Pharmaceuticals
SNOA
|
-2.88 | $ 3.82 | 1.33 % | $ 4.74 M | USA |
 |
OptiNose
OPTN
|
-0.2 | - | - | $ 1.08 B | USA |
 |
Assertio Holdings
ASRT
|
-3.03 | $ 9.4 | -0.32 % | $ 668 M | USA |
 |
PLx Pharma
PLXP
|
-1.72 | - | -27.8 % | $ 2.56 M | USA |
 |
Solid Biosciences
SLDB
|
-3.12 | $ 5.32 | -5.17 % | $ 217 M | USA |
 |
Tilray
TLRY
|
-2.22 | $ 9.13 | 1.57 % | $ 5.64 B | Canada |
 |
SCYNEXIS
SCYX
|
1.53 | $ 0.67 | 3.96 % | $ 32.1 M | USA |
 |
Tricida
TCDA
|
-2.97 | - | - | $ 3.25 M | USA |
 |
Veru
VERU
|
-0.27 | $ 2.32 | -2.11 % | $ 313 M | USA |
 |
TherapeuticsMD
TXMD
|
-0.73 | $ 2.01 | -1.62 % | $ 21 M | USA |
 |
cbdMD
YCBD
|
-0.66 | $ 1.1 | - | $ 4.74 M | USA |
 |
Viatris
VTRS
|
3.83 | $ 12.61 | 1.16 % | $ 15.3 B | USA |
 |
Zomedica Corp.
ZOM
|
-0.03 | - | -0.21 % | $ 98 M | USA |